Safety and Tolerability of ShigActive™, a Shigella spp. Targeting Bacteriophage Preparation, in a Phase 1 Randomized, Double-Blind, Controlled Clinical Trial.
Chen WH, Woolston J, Grant-Beurmann S, Robinson CK, Bansal G, Nkeze J, Permala-Booth J, Fraser CM, Tennant SM, Shriver MC, Pasetti MF, Liang Y, Kotloff KL, Sulakvelidze A, Schwartz JA.
Chen WH, et al. Among authors: bansal g.
Antibiotics (Basel). 2024 Sep 7;13(9):858. doi: 10.3390/antibiotics13090858.
Antibiotics (Basel). 2024.
PMID: 39335031
Free PMC article.